Abstract 5652: Translational evidence of reactivated innate and adaptive immunity with intratumoral IMO-2125 in combination with systemic checkpoint inhibitors from a Phase I/II study in patients with anti-PD-1 refractory metastatic melanoma

Name: Work Video:
Duration: 3 min 30 s
Cara Haymaker; Marc Uemura; Ravi Murthy; Marihella James; Daqing Wang; Julie Brevard; S. Swann; James Geib; Mark Cornfeld; Srinivas K. Chunduru; Sudhir Agrawal; Cassian Yee; Jennifer A. Wargo; Rodabe N. Amaria; Sapna P. Patel; Hussein A. Tawbi; Isabella C. Glitza; Scott E. Woodman; Wen‐Jen Hwu; Michael A. Davies; Patrick Hwu; Willem Overwjik; Chantale Bernatchez; Adi Diab
{'id': 'https://openalex.org/W2741276440', 'doi': 'https://doi.org/10.1158/1538-7445.am2017-5652', 'title': 'Abstract 5652: Translational evidence of reactivated innate and adaptive immunity with intratumoral IMO-2125 in combination with systemic checkpoint inhibitors from a Phase I/II study in patients with anti-PD-1 refractory metastatic melanoma', 'display_name': 'Abstract 5652: Translational evidence of reactivated innate and adaptive immunity with intratumoral IMO-2125 in combination with systemic checkpoint inhibitors from a Phase I/II study in patients with anti-PD-1 refractory metastatic melanoma', 'publication_year': 2017, 'publication_date': '2017-07-01', 'ids': {'openalex': 'https://openalex.org/W2741276440', 'doi': 'https://doi.org/10.1158/1538-7445.am2017-5652', 'mag': '2741276440'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2017-5652', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5050132330', 'display_name': 'Cara Haymaker', 'orcid': 'https://orcid.org/0000-0002-1317-9287'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Cara Haymaker', 'raw_affiliation_strings': ['1UT MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1UT MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035468368', 'display_name': 'Marc Uemura', 'orcid': 'https://orcid.org/0000-0002-6628-8356'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Marc Uemura', 'raw_affiliation_strings': ['1UT MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1UT MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5034845901', 'display_name': 'Ravi Murthy', 'orcid': 'https://orcid.org/0000-0003-1395-3890'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ravi Murthy', 'raw_affiliation_strings': ['1UT MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1UT MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112326932', 'display_name': 'Marihella James', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Marihella James', 'raw_affiliation_strings': ['1UT MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1UT MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038970528', 'display_name': 'Daqing Wang', 'orcid': 'https://orcid.org/0000-0002-4576-6734'}, 'institutions': [{'id': 'https://openalex.org/I4210142714', 'display_name': 'Idera Pharmaceuticals (United States)', 'ror': 'https://ror.org/03zts9g74', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210142714']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Daqing Wang', 'raw_affiliation_strings': ['2Idera Pharmaceuticals, Inc., Cambridge, MA.'], 'affiliations': [{'raw_affiliation_string': '2Idera Pharmaceuticals, Inc., Cambridge, MA.', 'institution_ids': ['https://openalex.org/I4210142714']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5072953400', 'display_name': 'Julie Brevard', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142714', 'display_name': 'Idera Pharmaceuticals (United States)', 'ror': 'https://ror.org/03zts9g74', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210142714']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Julie Brevard', 'raw_affiliation_strings': ['2Idera Pharmaceuticals, Inc., Cambridge, MA.'], 'affiliations': [{'raw_affiliation_string': '2Idera Pharmaceuticals, Inc., Cambridge, MA.', 'institution_ids': ['https://openalex.org/I4210142714']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109404831', 'display_name': 'S. Swann', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142714', 'display_name': 'Idera Pharmaceuticals (United States)', 'ror': 'https://ror.org/03zts9g74', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210142714']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Suzanne Swann', 'raw_affiliation_strings': ['2Idera Pharmaceuticals, Inc., Cambridge, MA.'], 'affiliations': [{'raw_affiliation_string': '2Idera Pharmaceuticals, Inc., Cambridge, MA.', 'institution_ids': ['https://openalex.org/I4210142714']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5080068791', 'display_name': 'James Geib', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142714', 'display_name': 'Idera Pharmaceuticals (United States)', 'ror': 'https://ror.org/03zts9g74', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210142714']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James Geib', 'raw_affiliation_strings': ['2Idera Pharmaceuticals, Inc., Cambridge, MA.'], 'affiliations': [{'raw_affiliation_string': '2Idera Pharmaceuticals, Inc., Cambridge, MA.', 'institution_ids': ['https://openalex.org/I4210142714']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017741773', 'display_name': 'Mark Cornfeld', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142714', 'display_name': 'Idera Pharmaceuticals (United States)', 'ror': 'https://ror.org/03zts9g74', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210142714']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mark Cornfeld', 'raw_affiliation_strings': ['2Idera Pharmaceuticals, Inc., Cambridge, MA.'], 'affiliations': [{'raw_affiliation_string': '2Idera Pharmaceuticals, Inc., Cambridge, MA.', 'institution_ids': ['https://openalex.org/I4210142714']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076733355', 'display_name': 'Srinivas K. Chunduru', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142714', 'display_name': 'Idera Pharmaceuticals (United States)', 'ror': 'https://ror.org/03zts9g74', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210142714']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Srinivas Chunduru', 'raw_affiliation_strings': ['2Idera Pharmaceuticals, Inc., Cambridge, MA.'], 'affiliations': [{'raw_affiliation_string': '2Idera Pharmaceuticals, Inc., Cambridge, MA.', 'institution_ids': ['https://openalex.org/I4210142714']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069014764', 'display_name': 'Sudhir Agrawal', 'orcid': 'https://orcid.org/0000-0003-4275-2510'}, 'institutions': [{'id': 'https://openalex.org/I4210142714', 'display_name': 'Idera Pharmaceuticals (United States)', 'ror': 'https://ror.org/03zts9g74', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210142714']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sudhir Agrawal', 'raw_affiliation_strings': ['2Idera Pharmaceuticals, Inc., Cambridge, MA.'], 'affiliations': [{'raw_affiliation_string': '2Idera Pharmaceuticals, Inc., Cambridge, MA.', 'institution_ids': ['https://openalex.org/I4210142714']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5028161783', 'display_name': 'Cassian Yee', 'orcid': 'https://orcid.org/0000-0002-4429-7307'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Cassian Yee', 'raw_affiliation_strings': ['1UT MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1UT MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035427219', 'display_name': 'Jennifer A. Wargo', 'orcid': 'https://orcid.org/0000-0003-3438-7576'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jennifer Wargo', 'raw_affiliation_strings': ['1UT MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1UT MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5029017725', 'display_name': 'Rodabe N. Amaria', 'orcid': 'https://orcid.org/0000-0001-6876-278X'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Rodabe Amaria', 'raw_affiliation_strings': ['1UT MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1UT MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035218748', 'display_name': 'Sapna P. Patel', 'orcid': 'https://orcid.org/0000-0003-1339-1517'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sapna Patel', 'raw_affiliation_strings': ['1UT MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1UT MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000768609', 'display_name': 'Hussein A. Tawbi', 'orcid': 'https://orcid.org/0000-0003-1942-851X'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Hussein Tawbi', 'raw_affiliation_strings': ['1UT MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1UT MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5114002330', 'display_name': 'Isabella C. Glitza', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Isabella Glitza', 'raw_affiliation_strings': ['1UT MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1UT MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006246174', 'display_name': 'Scott E. Woodman', 'orcid': 'https://orcid.org/0000-0002-1157-6991'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Scott Woodman', 'raw_affiliation_strings': ['1UT MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1UT MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5104110089', 'display_name': 'Wen‐Jen Hwu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Wen-Jen Hwu', 'raw_affiliation_strings': ['1UT MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1UT MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5048327749', 'display_name': 'Michael A. Davies', 'orcid': 'https://orcid.org/0000-0002-0977-0912'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michael A. Davies', 'raw_affiliation_strings': ['1UT MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1UT MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102918494', 'display_name': 'Patrick Hwu', 'orcid': 'https://orcid.org/0000-0003-0554-2856'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Patrick Hwu', 'raw_affiliation_strings': ['1UT MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1UT MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5028592227', 'display_name': 'Willem Overwjik', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Willem Overwjik', 'raw_affiliation_strings': ['1UT MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1UT MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5051328429', 'display_name': 'Chantale Bernatchez', 'orcid': 'https://orcid.org/0000-0001-5926-3460'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Chantale Bernatchez', 'raw_affiliation_strings': ['1UT MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1UT MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5030834372', 'display_name': 'Adi Diab', 'orcid': 'https://orcid.org/0000-0002-0153-0244'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Adi Diab', 'raw_affiliation_strings': ['1UT MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1UT MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.395, 'has_fulltext': False, 'cited_by_count': 3, 'citation_normalized_percentile': {'value': 0.615805, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 75, 'max': 77}, 'biblio': {'volume': '77', 'issue': '13_Supplement', 'first_page': '5652', 'last_page': '5652'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9992, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9992, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10580', 'display_name': 'Immunotherapy and Immune Responses', 'score': 0.998, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11491', 'display_name': 'CAR-T cell therapy research', 'score': 0.997, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/tumor-infiltrating-lymphocytes', 'display_name': 'Tumor-infiltrating lymphocytes', 'score': 0.41814414}], 'concepts': [{'id': 'https://openalex.org/C2781433595', 'wikidata': 'https://www.wikidata.org/wiki/Q2459042', 'display_name': 'Ipilimumab', 'level': 4, 'score': 0.8763684}, {'id': 'https://openalex.org/C2780057760', 'wikidata': 'https://www.wikidata.org/wiki/Q13896859', 'display_name': 'Pembrolizumab', 'level': 4, 'score': 0.8334096}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.71276546}, {'id': 'https://openalex.org/C2776107976', 'wikidata': 'https://www.wikidata.org/wiki/Q1786433', 'display_name': 'Tumor microenvironment', 'level': 3, 'score': 0.56210446}, {'id': 'https://openalex.org/C2777701055', 'wikidata': 'https://www.wikidata.org/wiki/Q1427096', 'display_name': 'Immunotherapy', 'level': 3, 'score': 0.46860588}, {'id': 'https://openalex.org/C2780030458', 'wikidata': 'https://www.wikidata.org/wiki/Q7041828', 'display_name': 'Nivolumab', 'level': 4, 'score': 0.46426013}, {'id': 'https://openalex.org/C2776090121', 'wikidata': 'https://www.wikidata.org/wiki/Q193529', 'display_name': 'T cell', 'level': 3, 'score': 0.46306983}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.4540407}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.4410652}, {'id': 'https://openalex.org/C2777658100', 'wikidata': 'https://www.wikidata.org/wiki/Q180614', 'display_name': 'Melanoma', 'level': 2, 'score': 0.4402608}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.4206168}, {'id': 'https://openalex.org/C2778326572', 'wikidata': 'https://www.wikidata.org/wiki/Q7852668', 'display_name': 'Tumor-infiltrating lymphocytes', 'level': 4, 'score': 0.41814414}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.36498487}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.34524065}, {'id': 'https://openalex.org/C8891405', 'wikidata': 'https://www.wikidata.org/wiki/Q1059', 'display_name': 'Immune system', 'level': 2, 'score': 0.3399731}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2017-5652', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.63}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4362545845', 'https://openalex.org/W4313890856', 'https://openalex.org/W4241093956', 'https://openalex.org/W4236421112', 'https://openalex.org/W3108601240', 'https://openalex.org/W3043703771', 'https://openalex.org/W2973740076', 'https://openalex.org/W2899127460', 'https://openalex.org/W2766929851', 'https://openalex.org/W2366936450'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'While': [2], 'checkpoint': [3, 371, 477], 'inhibitor': [4, 372], '(CPI)': [5], 'therapy': [6, 115], 'has': [7], 'transformed': [8], 'metastatic': [9, 489], 'melanoma': [10, 490], '(MM)': [11], 'treatment,': [12], 'many': [13], 'patients': [14, 256, 333, 485], 'remain': [15], 'refractory.': [16], 'We': [17, 66], 'reasoned': [18], 'that': [19, 25, 68, 109, 367, 384], 'combining': [20], 'CPI': [21], 'with': [22, 59, 85, 106, 144, 238, 253, 369, 470, 475, 486], 'an': [23, 286, 352], 'agent': [24], 'activates': [26], 'antigen': [27], 'presenting': [28], 'cells': [29], 'and': [30, 77, 141, 157, 167, 171, 178, 189, 200, 228, 313, 335, 397, 467], 'improves': [31], 'T-cell': [32, 191], 'priming': [33], 'may': [34], 'result': [35, 71], 'in': [36, 57, 72, 125, 163, 202, 211, 255, 291, 318, 327, 341, 345, 354, 357, 382, 402, 473, 484], 'improved': [37], 'response.': [38], 'Our': [39], 'approach': [40], 'is': [41, 132, 194, 222, 236, 373, 400], 'to': [42, 89, 130, 242, 260, 301, 377, 387], 'modulate': [43], 'the': [44, 53, 165, 226, 233, 272, 292, 328, 342, 358, 379, 395, 408, 495], 'tumor': [45, 155, 169, 264, 295], 'microenvironment': [46], 'through': [47], 'image-guided': [48], 'intratumoral': [49, 471], '(i.t.)': [50], 'injection': [51], 'of': [52, 79, 147, 232, 269, 271, 278, 311, 331, 337, 360, 393, 407, 464, 494], 'TLR9': [54], 'agonist,': [55], 'IMO-2125,': [56, 124], 'combination': [58, 399, 474], 'either': [60], 'ipilimumab': [61, 86, 148], '(ipi)': [62], 'or': [63, 87, 117, 149], 'pembrolizumab': [64, 88], '(pembro).': [65], 'hypothesize': [67], 'this': [69, 94], 'will': [70, 83], 'dendritic': [73], 'cell': [74, 186], '(DC)': [75], 'activation': [76, 180], 'induction': [78], 'tumor-specific': [80], 'CD8+T-cells': [81], 'which': [82], 'synergize': [84], 'overcome': [90], 'immune-escape.': [91], 'Based': [92], 'on': [93, 224], 'rationale': [95], 'we': [96], 'initiated': [97], 'a': [98, 119, 308, 346, 370, 374, 403, 480], 'phase': [99], 'I/II': [100, 482], 'clinical': [101, 245, 391], 'trial.': [102, 234, 410], 'Study': [103], 'Design/Methods:': [104], 'Adults': [105], 'refractory': [107, 259, 386, 488], 'MM': [108], 'have': [110, 250], 'had': [111], 'prior': [112], 'PD-1': [113, 261, 388], 'blockade': [114], '(with': [116], 'without': [118], 'BRAF': [120], 'inhibitor)': [121], 'are': [122, 153, 161, 206, 214, 385], 'eligible.': [123], 'doses': [126, 146], 'escalating': [127], 'from': [128, 479], '4mg': [129], '32mg,': [131], 'given': [133], 'i.t.': [134], 'weeks': [135], '1,': [136], '2,': [137], '3,': [138], '5,': [139], '8,': [140], '11': [142], 'along': [143], 'standard': [145], 'pembrolizumab.': [150], 'Primary': [151], 'endpoints': [152], 'safety,': [154], 'response,': [156], 'PK.': [158], 'Multiple': [159], 'biopsies': [160, 265], 'obtained': [162], 'both': [164, 225, 394], 'injected': [166, 294, 329], 'distant': [168, 343], 'pre-': [170], 'on-treatment.': [172], 'Immune': [173], 'analyses': [174], 'include': [175], 'DC': [176], 'subsets': [177], 'their': [179], 'status': [181], 'as': [182, 184, 283, 285], 'well': [183, 284], 'T': [185], 'activation,': [187], 'function': [188], 'proliferation.': [190], 'repertoire': [192], 'diversity': [193, 326], 'evaluated': [195], 'by': [196, 208, 280], 'high-throughput': [197], 'CDR3': [198, 322], 'sequencing': [199, 323], 'changes': [201], 'gene': [203, 289], 'expression': [204, 310], 'signatures': [205], 'assessed': [207, 217, 334], 'nanoString.': [209], 'Changes': [210], 'circulating': [212], 'cytokines': [213], 'also': [215], 'being': [216], 'during': [218], 'therapy.': [219], 'Results:': [220], 'Enrollment': [221], 'proceeding': [223], 'IMO-ipilimumab': [227, 254, 396], 'IMO-pembrolizumab': [229, 398], 'dose-escalation': [230], 'arms': [231], 'Safety': [235], 'acceptable': [237], 'no': [239], 'DLT': [240], 'recorded': [241], 'date.': [243], 'Durable': [244], 'responses': [246], '(including': [247], '1': [248], 'CR)': [249], 'been': [251], 'observed': [252], 'who': [257], 'were': [258], 'inhibitor.': [262], 'Fresh': [263], 'show': [266, 307], 'maturation': [267], '(upregulation': [268], 'HLA-DR)': [270], 'myeloid': [273], 'DC1': [274], 'subset': [275], '(CD1c+CD303-),': [276], 'upregulation': [277], 'PD-L1': [279], 'malignant': [281], 'cells,': [282], 'IFNα': [287], 'response': [288, 381], 'signature': [290], 'IMO-2125': [293, 368, 472], 'lesion': [296, 344], '24': [297], 'hrs': [298], 'post-treatment': [299], 'compared': [300], 'pre-treatment': [302], 'biopsy.': [303], 'On-treatment': [304], 'biopsy': [305], 'results': [306, 365], 'higher': [309], 'CD56+': [312], 'Ki67+': [314], 'effector': [315], 'CD8+': [316], 'T-cells': [317], 'responding': [319, 347, 361], 'patients.': [320, 362], 'Initial': [321], 'demonstrates': [324], 'increased': [325], 'lesions': [330], 'all': [332], 'expansion': [336, 406], 'top': [338], 'clones': [339], 'present': [340], 'patient.': [348], 'Plasma': [349], 'analysis': [350], 'showed': [351], 'increase': [353], 'IFNγ': [355], 'levels': [356], 'plasma': [359], 'Conclusions:': [363], 'These': [364], 'demonstrate': [366], 'viable': [375], 'strategy': [376], 'revive': [378], 'immune': [380], 'tumors': [383], 'inhibitors.': [389], 'Further': [390], 'evaluation': [392], 'planned': [401], 'Phase': [404, 481], '2': [405], 'current': [409], 'Citation': [411], 'Format:': [412], 'Cara': [413], 'Haymaker,': [414], 'Marc': [415], 'Uemura,': [416], 'Ravi': [417], 'Murthy,': [418], 'Marihella': [419], 'James,': [420], 'Daqing': [421], 'Wang,': [422], 'Julie': [423], 'Brevard,': [424], 'Suzanne': [425], 'Swann,': [426], 'James': [427], 'Geib,': [428], 'Mark': [429], 'Cornfeld,': [430], 'Srinivas': [431], 'Chunduru,': [432], 'Sudhir': [433], 'Agrawal,': [434], 'Cassian': [435], 'Yee,': [436], 'Jennifer': [437], 'Wargo,': [438], 'Rodabe': [439], 'Amaria,': [440], 'Sapna': [441], 'Patel,': [442], 'Hussein': [443], 'Tawbi,': [444], 'Isabella': [445], 'Glitza,': [446], 'Scott': [447], 'Woodman,': [448], 'Wen-Jen': [449], 'Hwu,': [450, 455], 'Michael': [451], 'A.': [452], 'Davies,': [453], 'Patrick': [454], 'Willem': [456], 'Overwjik,': [457], 'Chantale': [458], 'Bernatchez,': [459], 'Adi': [460], 'Diab.': [461], 'Translational': [462], 'evidence': [463], 'reactivated': [465], 'innate': [466], 'adaptive': [468], 'immunity': [469], 'systemic': [476], 'inhibitors': [478], 'study': [483], 'anti-PD-1': [487], '[abstract].': [491], 'In:': [492], 'Proceedings': [493], 'American': [496], 'Association': [497], 'for': [498], 'Cancer': [499, 512], 'Research': [500], 'Annual': [501], 'Meeting': [502], '2017;': [503], '2017': [504], 'Apr': [505], '1-5;': [506], 'Washington,': [507], 'DC.': [508], 'Philadelphia': [509], '(PA):': [510], 'AACR;': [511], 'Res': [513], '2017;77(13': [514], 'Suppl):Abstract': [515], 'nr': [516], '5652.': [517], 'doi:10.1158/1538-7445.AM2017-5652': [518]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2741276440', 'counts_by_year': [{'year': 2019, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}], 'updated_date': '2024-12-12T01:11:28.632074', 'created_date': '2017-08-08'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
